skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 26,923  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Recent developments in age-related macular degeneration: a review
Material Type:
Article
Add to My Research

Recent developments in age-related macular degeneration: a review

Clinical interventions in aging, 2017-01, Vol.12, p.1313-1330 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Al-Zamil and Yassin. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S143508 ;PMID: 28860733

Full text available

2
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Material Type:
Article
Add to My Research

Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration

Archives of ophthalmology (1960), 2021-04, Vol.139 (4), p.441 [Peer Reviewed Journal]

Copyright American Medical Association Apr 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2020.7085

Full text available

3
Age-related macular degeneration
Material Type:
Article
Add to My Research

Age-related macular degeneration

The Lancet (British edition), 2018-09, Vol.392 (10153), p.1147-1159 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31550-2 ;PMID: 30303083

Full text available

4
A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
Material Type:
Article
Add to My Research

A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration

Nature communications, 2019-07, Vol.10 (1), p.3347-11, Article 3347 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-11262-1 ;PMID: 31350409

Full text available

5
Mechanisms of age-related macular degeneration and therapeutic opportunities
Material Type:
Article
Add to My Research

Mechanisms of age-related macular degeneration and therapeutic opportunities

The Journal of pathology, 2014-01, Vol.232 (2), p.151-164 [Peer Reviewed Journal]

Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. ;ISSN: 0022-3417 ;EISSN: 1096-9896 ;DOI: 10.1002/path.4266 ;PMID: 24105633

Full text available

6
Predicting conversion to wet age-related macular degeneration using deep learning
Material Type:
Article
Add to My Research

Predicting conversion to wet age-related macular degeneration using deep learning

Nature medicine, 2020-06, Vol.26 (6), p.892-899 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0867-7 ;PMID: 32424211

Full text available

7
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options
Material Type:
Article
Add to My Research

Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options

British Journal of Ophthalmology, 2017-01, Vol.101 (1), p.25-30 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2016-308823 ;PMID: 27491360 ;CODEN: BJOPAL

Full text available

8
Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy
Material Type:
Article
Add to My Research

Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy

International journal of molecular sciences, 2021-01, Vol.22 (3), p.1170 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms22031170 ;PMID: 33504013

Full text available

9
Age-related macular degeneration
Material Type:
Article
Add to My Research

Age-related macular degeneration

The Lancet (British edition), 2012-05, Vol.379 (9827), p.1728-1738 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60282-7 ;PMID: 22559899

Full text available

10
Age-Related Macular Degeneration Revisited – Piecing the Puzzle: The LXIX Edward Jackson Memorial Lecture
Material Type:
Article
Add to My Research

Age-Related Macular Degeneration Revisited – Piecing the Puzzle: The LXIX Edward Jackson Memorial Lecture

American journal of ophthalmology, 2013, Vol.155 (1), p.1-35.e13 [Peer Reviewed Journal]

Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2012.10.018 ;PMID: 23245386 ;CODEN: AJOPAA

Full text available

11
Incidence and multimodal imaging characteristics of macular neovascularisation subtypes in Chinese neovascular age-related macular degeneration patients
Material Type:
Article
Add to My Research

Incidence and multimodal imaging characteristics of macular neovascularisation subtypes in Chinese neovascular age-related macular degeneration patients

British journal of ophthalmology, 2023-01, Vol.108 (3), p.391-397 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjo-2022-322392 ;PMID: 36639223

Full text available

12
Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration
Material Type:
Article
Add to My Research

Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration

American journal of ophthalmology, 2023-08, Vol.252, p.170-181 [Peer Reviewed Journal]

2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.03.033 ;PMID: 37030492

Full text available

13
The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retina
Material Type:
Article
Add to My Research

The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retina

Aging cell, 2020-02, Vol.19 (2), p.e13100-n/a [Peer Reviewed Journal]

2020 The Authors. published by the Anatomical Society and John Wiley & Sons Ltd. ;2020 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1474-9718 ;EISSN: 1474-9726 ;DOI: 10.1111/acel.13100 ;PMID: 31943697

Full text available

14
The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration
Material Type:
Article
Add to My Research

The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration

International journal of molecular sciences, 2021-11, Vol.22 (21), p.12049 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms222112049 ;PMID: 34769482

Full text available

15
Review of Fibrosis in Neovascular Age-Related Macular Degeneration
Material Type:
Article
Add to My Research

Review of Fibrosis in Neovascular Age-Related Macular Degeneration

American journal of ophthalmology, 2023-02, Vol.246, p.192-222 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.09.008 ;PMID: 36162537

Full text available

16
The eye as a complement dysregulation hotspot
Material Type:
Article
Add to My Research

The eye as a complement dysregulation hotspot

Seminars in immunopathology, 2018-01, Vol.40 (1), p.65-74 [Peer Reviewed Journal]

The Author(s) 2017 ;Seminars in Immunopathology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 1863-2297 ;EISSN: 1863-2300 ;DOI: 10.1007/s00281-017-0649-6 ;PMID: 28948331

Full text available

17
Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration
Material Type:
Article
Add to My Research

Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration

Graefe's archive for clinical and experimental ophthalmology, 2023-05, Vol.261 (5), p.1413-1421 [Peer Reviewed Journal]

The Author(s) 2022 ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-022-05885-2

Digital Resources/Online E-Resources

18
Associations and Outcomes of Patients with Submacular Hemorrhage Secondary to Age-related Macular Degeneration in the IVAN Trial
Material Type:
Article
Add to My Research

Associations and Outcomes of Patients with Submacular Hemorrhage Secondary to Age-related Macular Degeneration in the IVAN Trial

American journal of ophthalmology, 2022-04, Vol.236, p.89-98 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.09.033 ;PMID: 34626573

Full text available

19
Age-related macular degeneration-clinical review and genetics update
Material Type:
Article
Add to My Research

Age-related macular degeneration-clinical review and genetics update

Clinical genetics, 2013-08, Vol.84 (2), p.160-166 [Peer Reviewed Journal]

Published 2013. This article is a U.S. Government work and is in the public domain in the USA. ;2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2013 ;ISSN: 0009-9163 ;EISSN: 1399-0004 ;DOI: 10.1111/cge.12206 ;PMID: 23713713

Full text available

20
Emerging therapies and their delivery for treating age‐related macular degeneration
Material Type:
Article
Add to My Research

Emerging therapies and their delivery for treating age‐related macular degeneration

British journal of pharmacology, 2022-05, Vol.179 (9), p.1908-1937 [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15459 ;PMID: 33769566

Full text available

Results 1 - 20 of 26,923  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (20,578)

Refine My Results

Creation Date 

From To
  1. Before 1973  (15)
  2. 1973 To 1984  (179)
  3. 1985 To 1996  (451)
  4. 1997 To 2009  (7,332)
  5. After 2009  (18,916)
  6. More options open sub menu

Language 

  1. English  (25,875)
  2. Japanese  (2,885)
  3. German  (357)
  4. French  (283)
  5. Spanish  (186)
  6. Portuguese  (164)
  7. Chinese  (120)
  8. Russian  (100)
  9. Korean  (80)
  10. Turkish  (33)
  11. Norwegian  (25)
  12. Swedish  (12)
  13. Polish  (8)
  14. Croatian  (7)
  15. Czech  (6)
  16. Persian  (6)
  17. Icelandic  (5)
  18. Italian  (3)
  19. Serbian  (2)
  20. Bosnian  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait